<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Neuronal hyperexcitability and <z:mp ids='MP_0003674'>oxidative stress</z:mp> play critical roles in neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, we studied the effects of (2S,3S,4R)-N?-cyano-N-(6-amino-3,4-dihydro-3-hydroxy-2-<z:chebi fb="36" ids="29309">methyl</z:chebi>-2-dimethoxymethyl-2H-<z:chebi fb="0" ids="22727">benzopyran</z:chebi>-4-yl)-N'-benzylguanidine (KR-31378), possessing both <z:chebi fb="11" ids="22586">antioxidant</z:chebi> and <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel-modulating activities, on <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>-reperfusion injury models </plain></SENT>
<SENT sid="2" pm="."><plain>Treatment with KR-31378 (30 mg/kg, i.v.) significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> area and <z:hpo ids='HP_0000969'>edema</z:hpo> by 24% and 36%, respectively, in rats subjected to 2 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and 22 h of reperfusion with significant attenuation of elevated <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation (99% of <z:mpath ids='MPATH_458'>normal</z:mpath>) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> loss (60% of <z:mpath ids='MPATH_458'>normal</z:mpath>) in ischemic hemisphere </plain></SENT>
<SENT sid="3" pm="."><plain>We further studied its neuroprotective mechanism in fetal rat primary mixed cortical culture </plain></SENT>
<SENT sid="4" pm="."><plain>Incubation of cortical neurons with KR-31378 protected FeSO(4)-induced cell <z:hpo ids='HP_0011420'>death</z:hpo> in a concentration-dependent manner (IC(50)=12 microM) </plain></SENT>
<SENT sid="5" pm="."><plain>Its neuroprotective effect was neither mimicked by other <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel openers nor abolished in the presence of ATP-dependent <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel (K(ATP)) blockers, indicating that its effect was not related to <z:chebi fb="0" ids="29103">K(+)</z:chebi> channel opening activity </plain></SENT>
<SENT sid="6" pm="."><plain>The mechanism of protection is rather attributable to the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> property of KR-31378 since it suppressed the intracellular accumulation of reactive oxygen species and ensured <z:chebi fb="23" ids="18059">lipid</z:chebi> peroxidation by 120% and 80%, respectively, caused by FeSO(4) </plain></SENT>
<SENT sid="7" pm="."><plain>We further studied its effect on <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense, enzymatic and nonenzymatic systems </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment of neurons with FeSO(4) resulted in decrease of catalase (8% of control) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (14% of control) activities, which were restored by KR-31378 treatment (70% and 57% of control, respectively) </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, it attenuated the <z:mpath ids='MPATH_63'>depletion</z:mpath> of <z:chebi fb="0" ids="16856">glutathione</z:chebi> contents (60% of control) caused by FeSO(4) </plain></SENT>
<SENT sid="10" pm="."><plain>These results suggest that KR-31378 exerts a beneficial effect in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, which may be attributed to its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> property </plain></SENT>
</text></document>